Menu
Contact

Epilepsy Monitoring Devices Global Market Report 2022: Increasing Prevalence of Epilepsy Drives Adoption

December 16, 2022

Dublin, Dec. 16, 2022 (GLOBE NEWSWIRE) -- The "Epilepsy Monitoring Devices: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. This report provides an up-to-date overview and analysis of the global market for brain epilepsy monitoring devices. Epilepsy is a chronic, noncommunicable disease of the brain characterized by abnormal brain activity, resulting in seizures, which are brief episodes of involuntary movement that may involve a part of the body or the entire body and are sometimes accompanied by loss of consciousness and control of bowel or bladder function. Epilepsy in immature children makes it difficult for parents to monitor their children. Medical device companies have developed monitoring devices that help parents and doctors to monitor them easily. These devices can help and notify when a seizure occurs and protect against severe side effects from seizures. The adoption of the technology is based on factors such as the increasing prevalence and incidence of epilepsy, growing awareness about epilepsy, increasing use of wearable devices, and rising use of continuous monitoring devices. Increasing incidence and prevalence of epilepsy, growing awareness about epilepsy, and rising use of continuous monitoring devices are some of the key factors driving the growth of the current epilepsy monitoring devices market. However, the high cost of these devices and lack of public awareness about epilepsy monitoring devices is hindering market growth. Apart from drivers and restraints, increasing demand for non-invasive and minimally invasive devices is a huge opportunity for vendors in the market. In this report, the global epilepsy monitoring devices market has been segmented based on product type, end user and geography. Based on product type, the epilepsy monitoring devices market is categorized into conventional and wearable devices. Based on end user, the epilepsy monitoring devices market is segmented into home care end users and hospital and clinic end users. By geography, the epilepsy monitoring devices market is segmented into North America, Europe, Asia-Pacific, and the Rest of the (RoW). The North America region currently is the most dominant market for the global epilepsy monitoring devices market. The presence of leading global companies, increasing incidence and prevalence of epilepsy, and technological advancements are some of the key factors driving the North America market. Asia-Pacific is projected to be the fastest growing market for epilepsy monitoring devices globally. Report Includes An up-to-date overview and analysis of the global market for brain epilepsy monitoring devicesAnalyses of the global market trends, with historic revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027Estimation of the actual market size and revenue forecast for epilepsy monitoring devices market in USD million values, and corresponding market share analysis by product type, end user, and regionIdentification of the major stakeholders and analysis of the competitive landscape based on recent market developments and segmental revenuesCompany profiles of the leading global participants, including Abbott Laboratories, BioSerenity, Advanced Brain Monitoring Inc. and Epilert Key Topics Covered: Chapter 1 Market Outlook1.1 Market Snapshot Chapter 2 Executive Summary Chapter 3 Market Overview3.1 Introduction3.1.1 Disease Background3.1.2 Pathophysiology3.1.3 Classification of Seizures3.1.4 Classification of Epilepsy3.1.5 Epilepsy Monitoring Devices3.1.6 Wearable Devices3.1.7 Conventional Devices3.2 Market Dynamics3.2.1 Market Drivers3.2.1 Market Restraints3.2.1 Market Opportunities3.3 Impact of Covid-19 on the Epilepsy Monitoring Devices Chapter 4 Market Breakdown by Product Type4.1 Introduction4.2 Wearable Devices4.3 Conventional Devices Chapter 5 Market Breakdown by End-User5.1 Introduction5.2 Home Care5.3 Hospitals & Clinics Chapter 6 Market Breakdown by Region6.1 Market Overview and Discussion6.1.1 North America6.1.2 Europe6.1.3 Asia-Pacific6.1.4 Rest of the World (Row) Chapter 7 Competitive Landscape7.1 Global Company Ranking7.1.1 Recent News Chapter 8 Company Profiles Abbott LaboratoriesAdvanced Brain Monitoring Inc.Alert-ItBioserenityBoston Scientific Corp.Brain Sentinel Inc.Cadwell Industries Inc.Compumedics Ltd.Emfit Ltd.EmpaticaEpilertLivassured B.V.Masimo Corp.MedtronicMjn-NeuroNatus Medical Inc.Nihon Kohden Corp. Chapter 9 Project Scope and Methodology9.1 Scope of Report9.2 Methodology9.3 Analyst's Credentials9.4 Custom Research9.5 Related Research Reports Companies Mentioned Abbott LaboratoriesAdvanced Brain Monitoring Inc.Alert-ItBioserenityBoston Scientific Corp.Brain Sentinel Inc.Cadwell Industries Inc.Compumedics Ltd.Emfit Ltd.EmpaticaEpilertLivassured B.V.Masimo Corp.MedtronicMjn-NeuroNatus Medical Inc.Nihon Kohden Corp. For more information about this report visit https://www.researchandmarkets.com/r/o9yajv

© 2024 BrandPublished.com